Literature DB >> 24733090

Site-dependent recruitment of inflammatory cells determines the effective dose of Leishmania major.

Flavia L Ribeiro-Gomes1, Eric Henrique Roma2, Matheus B H Carneiro2, Nicole A Doria1, David L Sacks1, Nathan C Peters3.   

Abstract

The route of pathogen inoculation by needle has been shown to influence the outcome of infection. Employing needle inoculation of the obligately intracellular parasite Leishmania major, which is transmitted in nature following intradermal (i.d.) deposition of parasites by the bite of an infected sand fly, we identified differences in the preexisting and acute cellular responses in mice following i.d. inoculation of the ear, subcutaneous (s.c.) inoculation of the footpad, or inoculation of the peritoneal cavity (intraperitoneal [i.p.] inoculation). Initiation of infection at different sites was associated with different phagocytic populations. Neutrophils were the dominant infected cells following i.d., but not s.c. or i.p., inoculation. Inoculation of the ear dermis resulted in higher frequencies of total and infected neutrophils than inoculation of the footpad, and these higher frequencies were associated with a 10-fold increase in early parasite loads. Following inoculation of the ear in the absence of neutrophils, parasite phagocytosis by other cell types did not increase, and fewer parasites were able to establish infection. The frequency of infected neutrophils within the total infected CD11b(+) population was higher than the frequency of total neutrophils within the total CD11b(+) population, demonstrating that neutrophils are overrepresented as a proportion of infected cells. Employing i.d. inoculation to model sand fly transmission of parasites has significant consequences for infection outcome relative to that of s.c. or i.p. inoculation, including the phenotype of infected cells and the number of parasites that establish infection. Vector-borne infections initiated in the dermis likely involve adaptations to this unique microenvironment. Bypassing or altering this initial step has significant consequences for infection.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24733090      PMCID: PMC4097609          DOI: 10.1128/IAI.01600-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Infectivity of Plasmodium berghei sporozoites delivered by intravenous inoculation versus mosquito bite: implications for sporozoite vaccine trials.

Authors:  J A Vaughan; L F Scheller; R A Wirtz; A F Azad
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

2.  Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major.

Authors:  P A Bretscher; G Wei; J N Menon; H Bielefeldt-Ohmann
Journal:  Science       Date:  1992-07-24       Impact factor: 47.728

Review 3.  The skin as interface in the transmission of arthropod-borne pathogens.

Authors:  Freddy Frischknecht
Journal:  Cell Microbiol       Date:  2007-05-08       Impact factor: 3.715

4.  Parasite dose determines the Th1/Th2 nature of the response to Leishmania major independently of infection route and strain of host or parasite.

Authors:  J N Menon; P A Bretscher
Journal:  Eur J Immunol       Date:  1998-12       Impact factor: 5.532

5.  Rate of Leishmania-induced skin-lesion development in rodents depends on the site of inoculation.

Authors:  C E Kirkpatrick; T J Nolan; J P Farrell
Journal:  Parasitology       Date:  1987-06       Impact factor: 3.234

6.  In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies.

Authors:  Nathan C Peters; Jackson G Egen; Nagila Secundino; Alain Debrabant; Nicola Kimblin; Shaden Kamhawi; Phillip Lawyer; Michael P Fay; Ronald N Germain; David Sacks
Journal:  Science       Date:  2008-08-15       Impact factor: 47.728

7.  Quantification of the infectious dose of Leishmania major transmitted to the skin by single sand flies.

Authors:  Nicola Kimblin; Nathan Peters; Alain Debrabant; Nagila Secundino; Jackson Egen; Phillip Lawyer; Michael P Fay; Shaden Kamhawi; David Sacks
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-14       Impact factor: 11.205

8.  Infection of the upper respiratory tract with seasonal influenza A(H3N2) virus induces protective immunity in ferrets against infection with A(H1N1)pdm09 virus after intranasal, but not intratracheal, inoculation.

Authors:  Rogier Bodewes; Joost H C M Kreijtz; Geert van Amerongen; Marine L B Hillaire; Stella E Vogelzang-van Trierum; Nella J Nieuwkoop; Peter van Run; Thijs Kuiken; Ron A M Fouchier; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

9.  Site-specific immunity to Leishmania major in SWR mice: the site of infection influences susceptibility and expression of the antileishmanial immune response.

Authors:  G S Nabors; J P Farrell
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

10.  Platelet activation attracts a subpopulation of effector monocytes to sites of Leishmania major infection.

Authors:  Ricardo Goncalves; Xia Zhang; Heather Cohen; Alain Debrabant; David M Mosser
Journal:  J Exp Med       Date:  2011-05-23       Impact factor: 14.307

View more
  37 in total

1.  Immunomodulatory nanoparticles ameliorate disease in the Leishmania (Viannia) panamensis mouse model.

Authors:  Alyssa L Siefert; Allison Ehrlich; María Jesús Corral; Karen Goldsmith-Pestana; Diane McMahon-Pratt; Tarek M Fahmy
Journal:  Biomaterials       Date:  2016-09-06       Impact factor: 12.479

Review 2.  Permissive and protective roles for neutrophils in leishmaniasis.

Authors:  E D Carlsen; Y Liang; T R Shelite; D H Walker; P C Melby; L Soong
Journal:  Clin Exp Immunol       Date:  2015-08-28       Impact factor: 4.330

3.  Leishmania tropica: suggestive evidences for the effect of infectious dose on pathogenicity and immunogenicity in an experimental model.

Authors:  Mosayeb Rostamian; Davood Jafari; Maryam Abolghazi; Hadiseh Farahani; Hamid M Niknam
Journal:  Parasitol Res       Date:  2018-07-05       Impact factor: 2.289

4.  Animal models for the analysis of immune responses to leishmaniasis.

Authors:  D L Sacks; P C Melby
Journal:  Curr Protoc Immunol       Date:  2001-05

Review 5.  Cutaneous leishmaniasis: immune responses in protection and pathogenesis.

Authors:  Phillip Scott; Fernanda O Novais
Journal:  Nat Rev Immunol       Date:  2016-07-18       Impact factor: 53.106

6.  TLR2 Signaling in Skin Nonhematopoietic Cells Induces Early Neutrophil Recruitment in Response to Leishmania major Infection.

Authors:  Catherine Ronet; Katiuska Passelli; Mélanie Charmoy; Leo Scarpellino; Elmarie Myburgh; Yazmin Hauyon La Torre; Salvatore Turco; Jeremy C Mottram; Nicolas Fasel; Sanjiv A Luther; Stephen M Beverley; Pascal Launois; Fabienne Tacchini-Cottier
Journal:  J Invest Dermatol       Date:  2018-12-27       Impact factor: 8.551

7.  Twin Attributes of Tyrosyl-tRNA Synthetase of Leishmania donovani: A HOUSEKEEPING PROTEIN TRANSLATION ENZYME AND A MIMIC OF HOST CHEMOKINE.

Authors:  Sneha Anand; Rentala Madhubala
Journal:  J Biol Chem       Date:  2016-07-05       Impact factor: 5.157

8.  Leishmania donovani Metacyclic Promastigotes Impair Phagosome Properties in Inflammatory Monocytes.

Authors:  Christine Matte; Guillermo Arango Duque; Albert Descoteaux
Journal:  Infect Immun       Date:  2021-06-16       Impact factor: 3.441

9.  Dysregulation of Glycerophosphocholines in the Cutaneous Lesion Caused by Leishmania major in Experimental Murine Models.

Authors:  Adwaita R Parab; Diane Thomas; Sharon Lostracco-Johnson; Jair L Siqueira-Neto; James H McKerrow; Pieter C Dorrestein; Laura-Isobel McCall
Journal:  Pathogens       Date:  2021-05-13

Review 10.  New Therapeutic Tools to Shape Monocyte Functional Phenotypes in Leishmaniasis.

Authors:  Natália S Vellozo; Thaís S Rigoni; Marcela F Lopes
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.